Overview
- New figures show 64,425 men were diagnosed in 2022, overtaking breast cancer, with a 24% rise from 2021 and a 42% increase since 2012.
- The UK National Screening Committee advised against population PSA screening and supported biennial checks only for men with BRCA1 or BRCA2 mutations.
- Health Secretary Wes Streeting said he was surprised by the advice and has initiated a review during the 12-week consultation.
- Prostate Cancer UK and Sir Chris Hoy are urging changes so GPs can proactively offer PSA tests to higher‑risk men, rather than relying on men to request them.
- A major trial is evaluating PSA plus rapid MRI for potential population screening, while regional and deprivation gaps persist, including higher late‑stage diagnoses in Scotland.